It looks like your are using Internet Explorer.

Unfortunately, Internet Explorer is an outdated browser and we do not currently support it fully. You are seeing a limited view of the meeting details below.

To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

Best routes to market for DTx

31st May 2021 @ 10:30AM EDT

What are the most scalable and sustainable routes to market for DTx companies?


Beyond clinical evidence, the right commercialization model is key to drive adoption of DTx. A number of DTx companies have chosen pharma partnerships as their route to market, but is pharma the safest and most efficient commercialization model for DTx companies? Employer and payer partnerships have proven to be better options for some companies and D2C can also be a valuable approach, especially for new players that aim to gain traction faster and easily collect RWD to improve the product. An unexplored potential path is via medtech companies that are also seeking new ways to reach their customers. In this meeting we will have an informal chat around the understanding of the different routes to market and how they determine the success of a DTx product.


Apply to Attend

Thank you! Your submission has been received.

An invite invite link has been sent to you if you do not already have a HealthXL account.
Oops! Something went wrong while submitting the form.

Best routes to market for DTx

Todd Greenwood
Director, Evidence Generation and Outcomes Research, ZS
Louis Payet
Head of Mergers and Acquisitions at Zuellig Pharma
Apply to Attend

Best routes to market for DTx

No items found.

Join this HealthXL Event today:

Participate in this Digital Health Sprint in order to:
- Deep dive into a topic over 2 focused sessions.
- Engage with a small group of 10 global thought-leaders throughout.
- This sprint is outcome-focused: HealthXL and participants create exclusive outputs.
- Grow your network with our break out sessions.


You actively participate in this discussion. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.

Don't miss your opportunity to connect with senior leaders to shape the future of digital health. Because only if you are prepared now can you lead the future.

31st May 2021 @ 10:30AM EDT

What are the most scalable and sustainable routes to market for DTx companies?


Beyond clinical evidence, the right commercialization model is key to drive adoption of DTx. A number of DTx companies have chosen pharma partnerships as their route to market, but is pharma the safest and most efficient commercialization model for DTx companies? Employer and payer partnerships have proven to be better options for some companies and D2C can also be a valuable approach, especially for new players that aim to gain traction faster and easily collect RWD to improve the product. An unexplored potential path is via medtech companies that are also seeking new ways to reach their customers. In this meeting we will have an informal chat around the understanding of the different routes to market and how they determine the success of a DTx product.


Apply to AttendRegister to AttendApply to Attend

Participants

Participants

Todd Greenwood

Director, Evidence Generation and Outcomes Research, ZS

Louis Payet

Head of Mergers and Acquisitions at Zuellig Pharma

Kasparas Aleknavičius

Healthcare Futurist, Kilo.Health

Malin Johansson

Global Head of Digital Health Partnerships at Novo Nordisk

Robert Goldberg

Co-Founder and Chief Strategy Officer, Prosper Digital Therapeutics

Aahuti Rai

Strategic Advisor, Healthcare Innovation at Four Points Consulting Ltd

Christopher Hall

VP, Pharma at Mobio Interactive

Carlos Rodarte

Co-founder & CEO, Veriteos

Myles Furnace

Board Advisor, Stress Point Health

Ushma Baros

Partnerships, Big Health

Gulli Arnason

Chief Marketing & Communications Officer at SidekickHealth

Cathrine Heuch

CEO at Nordic Brain Tech AS

David Crimmins

Chief Commercial Officer, Webdoctor.ie

Number of Participants


Up to 12
Date  
May 31, 2021
Community

Best routes to market for DTx

What are the most scalable and sustainable routes to market for DTx companies?


Beyond clinical evidence, the right commercialization model is key to drive adoption of DTx. A number of DTx companies have chosen pharma partnerships as their route to market, but is pharma the safest and most efficient commercialization model for DTx companies? Employer and payer partnerships have proven to be better options for some companies and D2C can also be a valuable approach, especially for new players that aim to gain traction faster and easily collect RWD to improve the product. An unexplored potential path is via medtech companies that are also seeking new ways to reach their customers. In this meeting we will have an informal chat around the understanding of the different routes to market and how they determine the success of a DTx product.


Participate in the Meeting

HealthXL Roundtables

HealthXL community meetings connect senior leaders from around the world.

Our virtual Roundtables are small, participant-led discussions where the HealthXL community discuss digital health challenges and offer solutions.

Participant-Led

HealthXL community members lead discussion on a defined topic among a maximum of 12 participants. There is no audience and no recordings, just an interactive space to reflect and share learnings.

Developed for a Busy Schedule

At 60-minutes long, roundtables are long enough for meaningful discussion among peers, but short enough to fit into busy schedules.

Check out our platform for the full HealthXL experience

Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:

  • Join any virtual and in-person events
  • Invite peers to meetings
  • Network
  • Gain full access to all articles and HealthXL reports
  • Get personalised recommendations
  • Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
  • Full access to community insights and meeting takeaway reports

HealthXL Masterclasses

HealthXL community events give unparalleled access to digital health leaders from around the world.

Our virtual Masterclasses are 60-minute sessions where a recognised expert in their field provides an in-depth learning experience to a small audience of 8-12 members.

EXPERT-Led

HealthXL Masterclasses give you a chance to join a small group of peers and ask questions of recognised experts in a private, convenient setting.

Check out our platform for the full HealthXL experience

Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:

  • Join any virtual and in-person events
  • Invite peers to meetings
  • Network
  • Gain full access to all articles and HealthXL reports
  • Get personalised recommendations
  • Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
  • Full access to community insights and meeting takeaway reports

HealthXL Webinars

HealthXL community events give unparalleled access to digital health experts from around the world.

Our webinars bring together panels of 3-4 global leaders from the HealthXL community to discuss core trends in digital health.

Expert Panel Discussion

Gain insights on the latest topics in digital health and ask questions of the expert panel via chat. Webinars run for 60 minutes and recordings are shared with all attendees afterwards.

Check out our platform for the full HealthXL experience

Set up a free HealthXL platform account for a taste of what the community has to offer. Or talk to us about upgrading to a premium account:

  • Join any virtual and in-person events
  • Invite peers to meetings
  • Network
  • Gain full access to all articles and HealthXL reports
  • Get personalised recommendations
  • Join specialised communities in areas like DTx, AI, Clinical Trials Innovation and more
  • Full access to community insights and meeting takeaway reports
Virtual Digital Health Meeting

Join from anywhere

No need for a high end laptop to display fancy 3D personas or interactive conference rooms: All you need is a working camera and an internet-ready device to join.

Apply to Attend now

The world of Digital Health in one Hub

Be ready for the future of Digital Health and join a community of passionate leaders, innovators and gamechangers. 

As a HealthXL member, you get access to a wealth of information, resources and connections. From daily curated news by our in-house expert team to industry reports each retailing at €2000 - you have the world of Digital Health right at your fingertips.

Our community is growing fast. Don’t miss out on your opportunity to lead the future.


Join the community here
Reports & Insights
Reports and insights shared by the DTx community
Curated
News
Daily DTx News Curated by our in-house experts
Lists & Dashboards
Interactive dashboards and downloadable organisation data

Your Digital Health Corner

All Posts
Events
March 13, 2024
#ViVE2024 Unwrapped: Highlights and Insights
#ViVE2024 Unwrapped: Highlights and Insights
Read More
Commentary
February 16, 2024
Tess’ Top Takes from this Month’s Meetings in Digital Health: February 2024
Tess’ Top Takes from this Month’s Meetings in Digital Health: February 2024
Read More
Commentary
February 9, 2024
Is There a Space for Digital Health in the World of RNA Based Therapeutics?
Is There a Space for Digital Health in the World of RNA Based Therapeutics?
Read More

Best routes to market for DTx

31st May 2021 @ 10:30AM EDT
Digital Therapeutics (DTx)

Best routes to market for DTx

31st May 2021 @ 10:30AM EDT
Digital Therapeutics (DTx)
Todd Greenwood
Director, Evidence Generation and Outcomes Research, ZS
LinkedIn Profile
Louis Payet
Head of Mergers and Acquisitions at Zuellig Pharma
LinkedIn Profile
Kasparas Aleknavičius
Healthcare Futurist, Kilo.Health
LinkedIn Profile
Malin Johansson
Global Head of Digital Health Partnerships at Novo Nordisk
LinkedIn Profile
Robert Goldberg
Co-Founder and Chief Strategy Officer, Prosper Digital Therapeutics
LinkedIn Profile
Aahuti Rai
Strategic Advisor, Healthcare Innovation at Four Points Consulting Ltd
LinkedIn Profile
Christopher Hall
VP, Pharma at Mobio Interactive
LinkedIn Profile
Carlos Rodarte
Co-founder & CEO, Veriteos
LinkedIn Profile
Myles Furnace
Board Advisor, Stress Point Health
LinkedIn Profile
Ushma Baros
Partnerships, Big Health
LinkedIn Profile
Gulli Arnason
Chief Marketing & Communications Officer at SidekickHealth
LinkedIn Profile
Cathrine Heuch
CEO at Nordic Brain Tech AS
LinkedIn Profile
David Crimmins
Chief Commercial Officer, Webdoctor.ie
LinkedIn Profile

Best routes to market for DTx

What are the most scalable and sustainable routes to market for DTx companies?


Beyond clinical evidence, the right commercialization model is key to drive adoption of DTx. A number of DTx companies have chosen pharma partnerships as their route to market, but is pharma the safest and most efficient commercialization model for DTx companies? Employer and payer partnerships have proven to be better options for some companies and D2C can also be a valuable approach, especially for new players that aim to gain traction faster and easily collect RWD to improve the product. An unexplored potential path is via medtech companies that are also seeking new ways to reach their customers. In this meeting we will have an informal chat around the understanding of the different routes to market and how they determine the success of a DTx product.


When:
31st May 2021 @ 10:30AM EDT
Apply to attend
Registration Closed

Join this group of peers and get a feel of what it's like to belong to a community of digital health gamechangers.

All meetings are limited to 10 people to allow for honest discussions, so apply fast or become a HealthXL member and get priority access to all meetings, latest industry reports and and much more.

Frequently asked questions: 

What are HealthXL Virtual Meetings?

HealthXL Virtual Meetings are private group meetings limited to 10 people across different demographic and stakeholder groups. For 75 minutes, you take a deep dive into your chosen topic and explore it from different angles. Virtual Meetings are not webinars: There is no audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And through our Community Hub, you stay up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

How can I connect with other digital health leaders?

HealthXL brings together gamechangers of digital health to support honest discussions in small, private groups. In our Community Hub, for which you can register for free, you can follow a wide range of communities across telehealth, digital therapeutics, patient engagement and more. As a full HealthXL member, you also get access to curated news, the latest insights and an expert network to connect with. Join exclusive virtual meetings to exchange strategies, viewpoints and learnings with members from like-minded yet diverse stakeholder groups.

What are the benefits of being a HealthXL community member?

As member of HealthXL, you join a community of digital health thought leaders, innovators and game changers around the world. With your membership, you get access to hundreds of insights, reports and resources. You can browse a database with over 90k healthcare organizations and view their active strategic partnerships, commercial relationships, latest funding rounds and research. Through our in-house curated digital health newsfeed, you stay informed on the most impactful news and you can regularly meet with members to share learnings, discuss the latest developments and connect with peers of different demographical stakeholder groups. Contact us today to find out about pricing options.

Through focus groups, we bring together 6-10 thought leaders and industry stakeholders in a series of virtual meetings to collaborate around a defined topic. Each meeting gives the group the opportunity to examine, analyze and collaborate with one another around a digital health topic as well as produce a shareable result.